Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
151,803,139
-
Total 13F shares
-
152,930,142
-
Share change
-
+8,839,216
-
Total reported value
-
$1,136,092,939
-
Put/Call ratio
-
108%
-
Price per share
-
$7.43
-
Number of holders
-
222
-
Value change
-
+$68,698,964
-
Number of buys
-
108
-
Number of sells
-
84
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q1 2025
As of 31 Mar 2025,
Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
152,930,142 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, Rubric Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, ARK Investment Management LLC, AMERIPRISE FINANCIAL INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., BRAIDWELL LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
222
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.